Published in Eur J Pediatr on August 01, 2000
Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol (2004) 3.57
The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev (2008) 3.56
Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol (2003) 3.01
Wolcott-Rallison syndrome. Orphanet J Rare Dis (2010) 1.45
PERK eIF2 alpha kinase is required to regulate the viability of the exocrine pancreas in mice. BMC Cell Biol (2007) 1.23
The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in β-cells. Diabetes Obes Metab (2010) 1.14
Endoplasmic reticulum stress in the β-cell pathogenesis of type 2 diabetes. Exp Diabetes Res (2011) 0.98
A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS). Am J Med Genet A (2012) 0.84
Frequency and spectrum of Wolcott-Rallison syndrome in Saudi Arabia: a systematic review. Libyan J Med (2013) 0.82
Primary hypothyroidism: an unusual manifestation of Wolcott-Rallison syndrome. Eur J Pediatr (2013) 0.77
Novel mutation in wolcott-rallison syndrome with variable expression in two omani siblings. Oman Med J (2015) 0.75
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (1994) 4.04
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet (2001) 3.50
Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet (1997) 3.37
Clinical features of 52 neonates with hyperinsulinism. N Engl J Med (1999) 3.35
An adenovirus vector for gene transfer into neurons and glia in the brain. Science (1993) 2.79
Intelligent Medical Record--entry (IMR-E). J Med Syst (1993) 2.55
UMLS-based conceptual queries to biomedical information databases: an overview of the project ARIANE. Unified Medical Language System. J Am Med Inform Assoc (1998) 2.34
SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet (1998) 2.30
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
Congenital lumbosacral lipomas. Childs Nerv Syst (1997) 2.11
Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A (2004) 1.99
X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet (1994) 1.97
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet (1992) 1.95
Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet (1995) 1.88
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet (2002) 1.84
FGFR2 mutations in Pfeiffer syndrome. Nat Genet (1995) 1.82
Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest (1997) 1.64
Genitopatellar syndrome: a new condition comprising absent patellae, scrotal hypoplasia, renal anomalies, facial dysmorphism, and mental retardation. J Med Genet (2000) 1.62
Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet (1997) 1.59
Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest (1998) 1.58
Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics (2001) 1.53
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest (1998) 1.52
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet (1996) 1.50
Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet (1997) 1.49
Sulphate transporter gene mutations in apparently isolated club foot. J Med Genet (2001) 1.47
Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients. Eur J Endocrinol (2014) 1.46
Facial anomalies in D-2-hydroxyglutaric aciduria. Am J Med Genet (1999) 1.42
A gene for Meckel syndrome maps to chromosome 11q13. Am J Hum Genet (1998) 1.42
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia (1997) 1.40
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients. Diabetes Care (1995) 1.40
Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet (2001) 1.40
A conceptual model for information retrieval with UMLS. Proc Annu Symp Comput Appl Med Care (1993) 1.39
A new lethal syndrome of exomphalos, short limbs, and macrogonadism. J Med Genet (1999) 1.39
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38
Genetic study of scaphocephaly. Am J Med Genet (1996) 1.34
A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet (2001) 1.34
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet (1995) 1.27
Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet (2003) 1.26
Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev (1998) 1.25
ARIANE: integration of information databases within a hospital intranet. Int J Med Inform (1998) 1.19
COL9A3: A third locus for multiple epiphyseal dysplasia. Am J Hum Genet (1999) 1.17
Clinical, radiological, and chondro-osseous findings in opsismodysplasia: survey of a series of 12 unreported cases. J Med Genet (2003) 1.16
Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients. Pediatr Res (2001) 1.15
Clinical variability in patients with Apert's syndrome. J Neurosurg (1999) 1.15
Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet (1996) 1.14
Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1997) 1.14
The molecular basis of X-linked spondyloepiphyseal dysplasia tarda. Am J Hum Genet (2001) 1.12
Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia (1996) 1.12
Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet (2001) 1.11
Atypical findings in Kabuki syndrome: report of 8 patients in a series of 20 and review of the literature. Am J Med Genet A (2004) 1.08
Syndromal and nonsyndromal primary trigonocephaly: analysis of a series of 237 patients. Am J Med Genet (1998) 1.08
Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. J Med Genet (2004) 1.07
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine, alanine, and glycine. Diabetes (1985) 1.07
Glucose and insulin effects on the novo amino acid synthesis in young men: studies with stable isotope labeled alanine, glycine, leucine, and lysine. Metabolism (1982) 1.07
Neural tube defects in France: segregation analysis. Am J Med Genet (1982) 1.06
Twenty-five novel mutations including duplications in the ATP7A gene. Clin Genet (2011) 1.06
IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J Clin Endocrinol Metab (1999) 1.05
Clinical homogeneity of the Stüve-Wiedemann syndrome and overlap with the Schwartz-Jampel syndrome type 2. Am J Med Genet (1998) 1.05
Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis (1996) 1.04
A novel microsatellite DNA marker at locus D7S1870 detects hemizygosity in 75% of patients with Williams syndrome. Am J Hum Genet (1995) 1.04
Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum Genet (2001) 1.03
Visual evoked potentials in diabetic children and adolescents. Diabetes Care (1984) 1.02
Mutations within or upstream of the basic helix-loop-helix domain of the TWIST gene are specific to Saethre-Chotzen syndrome. Eur J Hum Genet (1999) 1.01
Revisiting metatropic dysplasia: presentation of a series of 19 novel patients and review of the literature. Am J Med Genet A (2008) 1.00
Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 1.00
SHOX point mutations in dyschondrosteosis. J Med Genet (2001) 1.00
Fibroblast growth factor receptor 3 mutation in nonsyndromic coronal synostosis: clinical spectrum, prevalence, and surgical outcome. J Neurosurg (2000) 1.00
Adenoviral vectors as functional retrograde neuronal tracers. Brain Res (1994) 0.99
Quantitative aspects of glucose production and metabolism in healthy elderly subjects. Diabetes (1982) 0.99
A conceptual graphs modeling of UMLS components. Medinfo (1995) 0.99
Stüve-Wiedemann syndrome: long-term follow-up and genetic heterogeneity. Clin Genet (2010) 0.99
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr (1999) 0.98
Homozygosity mapping of a Desbuquois dysplasia locus to chromosome 17q25.3. J Med Genet (2003) 0.98
Aminopyrimidine-carboxyl(ate) interactions in trimethoprim maleate, an antifolate drug. Acta Crystallogr C (2001) 0.98
The gene for spondyloepiphyseal dysplasia (SEDL) maps to Xp22 between DXS16 and DXS92. Genomics (1993) 0.97
Homozygosity mapping of a Dyggve-Melchior-Clausen syndrome gene to chromosome 18q21.1. J Med Genet (2002) 0.97
Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritance. J Med Genet (2001) 0.96
Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol (2001) 0.96
Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter. Gene Ther (1999) 0.96
Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families. J Clin Endocrinol Metab (1997) 0.95
A novel automated strategy for screening cryptic telomeric rearrangements in children with idiopathic mental retardation. Eur J Hum Genet (2001) 0.95
Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet (1996) 0.95
Wide clinical variability among 13 new Cockayne syndrome cases confirmed by biochemical assays. Arch Dis Child (2006) 0.95
Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm Res (1996) 0.95
Clinical variability and genetic homogeneity of the camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Am J Med Genet (2000) 0.94
An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet (1997) 0.94
Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes (1996) 0.94
Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia. Eur J Hum Genet (1998) 0.94
Increased paternal age in CHARGE association. Clin Genet (1996) 0.93
X-linked hydrocephalus: clinical heterogeneity at a single gene locus. Eur J Pediatr (1992) 0.93
The project ARIANE: conceptual queries to information databases. Proc AMIA Annu Fall Symp (1996) 0.92
Segregation analysis in nonsyndromic holoprosencephaly. Am J Med Genet (1998) 0.92
CFC syndrome: a syndrome distinct from Noonan syndrome. Ann Genet (1988) 0.92
Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation. J Med Genet (1999) 0.92
A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab (1999) 0.91
Molecular cytogenetic analysis of five 2q37 deletions: refining the brachydactyly candidate region. Eur J Med Genet (2005) 0.91